After a three-year run in which drug-coated stents grew into one of the most profitable, fastest-selling medical devices in history, doctors appear to be using fewer of them. As more evidence suggests drug-coated stents have caused higher rates of blood clots, doctors at many hospitals have recently begun shifting toward older, bare-metal stents. In the third quarter, drug-eluting stents represented 86% of stents used in heart-repair procedures at 78 hospitals, down from 88% in the previous quarter, according to data from Goodroe Healthcare Solutions. Its the first time that were aware of that theres been even a 2% decrease, said Joane Goodroe, the companys president.
Drug-coated stents may be losing favor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.